key: cord-1019822-hyj07olc
authors: Duan, Zhihui; Zhou, Shengyun; Niu, Zongxian
title: Use of the Glasgow-Blatchford score during the COVID-19 pandemic needs more rigorous research
date: 2020-11-19
journal: Endoscopy
DOI: 10.1055/a-1300-2132
sha: 57d744bdb27f0b017bba8a3837a3a5e3ebea2399
doc_id: 1019822
cord_uid: hyj07olc

nan

A very important paper by Young-II Kim et al. [1] was published recently in Endoscopy. The authors found that the Glasgow-Blatchford score (GBS) was inferior to the Rockall score in predicting the need for urgent hemostatic intervention for tumor-associated upper gastrointestinal bleeding (UGIB), leading to poor performance (area under the receiver operating characteristic curve [AUROC] 0.56). This study is crucial for patient risk stratification for UGIB during the COVID-19 pandemic, and we would like to draw your attention toward it. The COVID-19 pandemic has severely affected the practice of gastrointestinal (GI) endoscopy worldwide because upper GI endoscopy has been recognized as an aerosol-generating procedure that increases the risk of COVID-19 infection [2] . Thus, the endoscopic management of patients with UGIB now presents a dilemma. The pre-endoscopy risk scores, such as GBS, are based on pre-pandemic research and have not been validated by large-scale studies during the COVID-19 pandemic. A recent case series [3] has shown that six UGIB patients with COVID and GBS > 7 did not require endoscopy and were conservatively managed, which did not accord with the relevant European Society for Gastrointestinal Endoscopy (ESGE) guideline [4] . The latter recommends only that patients with a GBS score of 0 -1 do not require endoscopy. Thus, the performance of the GBS has seemed to be especially limited during the COVID-19 pandemic [3] . According to Laursen et al. [5] , the low-risk threshold for defining UGIB patients who do not require inpatient endoscopy and hospitalization could be increased to GBS < 3.

In conclusion, the COVID-19 pandemic remains a worldwide challenge, and its impact on GI endoscopy and UGIB detection could be increasingly significant. Raising the GBS threshold or developing a new and accurate risk score before endoscopy in UGIB patients will be critical in the prevention of a UGIB healthcare crisis. We hope a more rigorous study will be conducted in the near future.

Comparison of the performance of risk scoring systems for tumor bleeding in patients with inoperable gastric cancer

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and the COVID-19 pandemic

Management of upper GI bleeding in patients with COVID-19 pneumonia

Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Raising the threshold for hospital admission and endoscopy in upper gastrointestinal bleeding during the COVID-19 pandemic

The authors declare no conflicts of interest.

Zhihui Duan, Shengyun Zhou, Zongxian Niu